journal article Oct 01, 2012

Pharmacogenomics Knowledge for Personalized Medicine

M Whirl-Carrillo E M McDonagh J M Hebert L Gong K Sangkuhl C F Thorn R B Altman T E Klein

Clinical Pharmacology & Therapeutics Vol. 92 No. 4 pp. 414-417 · Wiley

View at Publisher Save 10.1038/clpt.2012.96

Topics

No keywords indexed for this article. Browse by subject →

References

4

[1]

10.2217/bmm.11.94

[2]

[3]

[4]

10.1038/clpt.2010.279

Cited By

1,559

Drug-drug interactions prediction based on deep learning and knowledge graph: A review

Huimin Luo, Weijie Yin · 2024

iScience

Potential mechanisms of traditional Chinese medicine in treating insomnia: A network pharmacology, GEO validation, and molecular-docking study

Xing Liu, Pengcheng Sun · 2024

Medicine

The therapeutic landscape for COVID-19 and post-COVID-19 medications from genetic profiling of the Vietnamese population and a predictive model of drug-drug interaction for comorbid COVID-19 patients

Thien Khac Nguyen, Giang Minh Vu · 2024

Heliyon

Pharmacogenomics: current status and future perspectives

Munir Pirmohamed · 2023

Nature Reviews Genetics

Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists

Erin K. McCreary, Matthew R. Davis · 2023

Pharmacotherapy: The Journal of Hum...

A comprehensive survey of the approaches for pathway analysis using multi-omics data integration

Zeynab Maghsoudi, Ha Nguyen · 2022

Briefings in Bioinformatics

LaGAT: link-aware graph attention network for drug–drug interaction prediction

Yue Hong, Pengyu Luo · 2022

Bioinformatics

Investigation of target sequencing of SARS-CoV-2 and immunogenic GWAS profiling in host cells of COVID-19 in Vietnam

Tham H. Hoang, Giang M. Vu · 2022

BMC Infectious Diseases

Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

Stein Bergan, Mercè Brunet · 2021

Therapeutic Drug Monitoring

An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine

Michelle Whirl‐Carrillo, Rachel Huddart · 2021

Clinical Pharmacology & Therape...

Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis

Jiaqin Liu, Jian Liu · 2021

Drug Design, Development and Therap...

Developing a Gene Panel for Pharmacoresistant Epilepsy: A Review of Epilepsy Pharmacogenetics

Astrid J Rodriguez-Acevedo, Louisa G Gordon · 2021

Pharmacogenomics

PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge

Li Gong, Michelle Whirl‐Carrillo · 2021

Current Protocols

Ecotoxicity of losartan potassium in aquatic organisms of different trophic levels

Regiane Reque, Rhaissa Dayane Carneiro · 2021

Environmental Toxicology and Pharma...

The application of cytokeratin-18 as a biomarker for drug-induced liver injury

Samantha Korver, Joanne Bowen · 2021

Archives of Toxicology

Fast mutual exclusivity algorithm nominates potential synthetic lethal gene pairs through brute force matrix product computations

Tarcisio Fedrizzi, Yari Ciani · 2021

Computational and Structural Biotec...

Integrated Informatics Analysis of Cancer-Related Variants

Kymberleigh A. Pagel, Rick Kim · 2020

JCO Clinical Cancer Informatics

Essentiality and Transcriptome-Enriched Pathway Scores Predict Drug-Combination Synergy

Jin Li, Yang Huo · 2020

Biology

PubChem in 2021: new data content and improved web interfaces

Sunghwan Kim, Jie Chen · 2020

Nucleic Acids Research

Review and Consensus on Pharmacogenomic Testing in Psychiatry

Chad A. Bousman, Susanne A. Bengesser · 2020

Pharmacopsychiatry

Metrics

1,559

Citations

4

References

Details

Published: Oct 01, 2012
Vol/Issue: 92(4)
Pages: 414-417

Authors

M Whirl-Carrillo

Cite This Article

M Whirl-Carrillo, E M McDonagh, J M Hebert, et al. (2012). Pharmacogenomics Knowledge for Personalized Medicine. Clinical Pharmacology & Therapeutics, 92(4), 414-417. https://doi.org/10.1038/clpt.2012.96

Related

You May Also Like

A method for estimating the probability of adverse drug reactions

C A Naranjo, U Busto · 1981

9,034 citations

Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

G P Aithal, P B Watkins · 2011

879 citations

An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine

Michelle Whirl‐Carrillo, Rachel Huddart · 2021

693 citations

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update

JA Johnson, KE Caudle · 2017

611 citations

Cigarette Smoking, Nicotine, and Body Weight

J Audrain-McGovern, N L Benowitz · 2011

467 citations